CAH is often detected through newborn screening tests, which measure levels of 17-hydroxyprogesterone (17-OHP) in a blood sample. Elevated levels of 17-OHP may indicate CAH. Early diagnosis is crucial as it allows for prompt treatment, reducing the risk of severe complications. Confirmatory tests include additional hormone assays and genetic testing to identify the specific enzyme deficiency.
